Diagnosis and treatment of iron deficiency in patients with heart failure: Expert position paper from French cardiologists

Archives of Cardiovascular Diseases

Volumn 107, Issue 10, 2014, Pages 563-571

  Cohen Solal, Alain ^a   Leclercq, Christophe ^b   Mebazaa, Alexandre ^a   De Groote, Pascal ^c   Damy, Thibaud ^d   Isnard, Richard ^e   Galinier, Michel ^f  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f CHU RANGUEIL   (France)

Author keywords

Heart failure; Intravenous iron; Iron deficiency; Serum ferritin; Transferrin saturation

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; IRON; TRANSFERRIN;

CARDIOLOGIST; CELL TRANSPORT; CLINICAL EVALUATION; EXERCISE; FERRITIN BLOOD LEVEL; FRANCE; HEART FAILURE; HUMAN; IRON DEFICIENCY; IRON STORAGE; IRON TRANSPORT; MULTICENTER STUDY (TOPIC); NEW YORK HEART ASSOCIATION CLASS; NONHUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SUPPLEMENTATION; ANEMIA, IRON-DEFICIENCY; BLOOD; COMPLICATION; DISEASE MANAGEMENT;

ANEMIA, IRON-DEFICIENCY; BIOLOGICAL MARKERS; DISEASE MANAGEMENT; FRANCE; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84908290448     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2014.07.049     Document Type: Short Survey

References (39)

1. Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency:an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010;31:1872-80.
2. Klip IT, Comin-Colet J, Voors AA, et al. Iron deficiency in chronicheart failure: an international pooled analysis. Am Heart J 2013;165:575-82 [e3].
3. Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA. Disor-dered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and sur-vival. J Am Coll Cardiol 2011;58:1241-51.
4. Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxy-maltose in patients with heart failure and iron deficiency. NEngl J Med 2009;361:2436-48.
5. Bolger AP, Bartlett FR, Penston HS, et al. Intravenous iron alonefor the treatment of anemia in patients with chronic heartfailure. J Am Coll Cardiol 2006;48:1225-7.
6. Okonko DO, Grzeslo A, Witkowski T, et al. Effect of intravenousiron sucrose on exercise tolerance in anemic and nonanemicpatients with symptomatic chronic heart failure and iron defi-ciency FERRIC-HF: a randomized, controlled, observer-blindedtrial. J Am Coll Cardiol 2008;51:103-12.
7. Toblli JE, Lombrana A, Duarte P, Di Gennaro F. Intravenous ironreduces NT-pro-brain natriuretic peptide in anemic patientswith chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007;50:1657-65.
8. Usmanov RI, Zueva EB, Silverberg DS, Shaked M. Intravenousiron without erythropoietin for the treatment of iron defi-ciency anemia in patients with moderate to severe congestiveheart failure and chronic kidney insufficiency. J Nephrol 2008;21:236-42.
9. Haas JD, Brownlie T. Iron deficiency and reduced work capac-ity: a critical review of the research to determine a causalrelationship. J Nutr 2001;131:676S-88S [Discussion 88S-90S].
10. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-95.
11. Cairo G, Bernuzzi F, Recalcati S. A precious metal: iron, anessential nutrient for all cells. Genes Nutr 2006;1:25-39.
12. Geisser P, Burckhardt S. The pharmacokinetics and pharmaco-dynamics of iron preparations. Pharmaceutics 2011;3:12-33.
13. De Domenico I, McVey Ward D, Kaplan J. Regulation of ironacquisition and storage: consequences for iron-linked disor-ders. Nat Rev Mol Cell Biol 2008;9:72-81.
14. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl JMed 2005;352:1011-23.
15. Wessling-Resnick M. Iron homeostasis and the inflammatoryresponse. Annu Rev Nutr 2010;30:105-22.
16. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, isa type II acute-phase protein. Blood 2003;101:2461-3.
17. Cui Y, Wu Q, Zhou Y. Iron-refractory iron deficiency anemia:new molecular mechanisms. Kidney Int 2009;76:1137-41.
18. Dong F, Zhang X, Culver B, Chew Jr HG, Kelley RO, Ren J. Dietary iron deficiency induces ventricular dilation, mitochon-drial ultrastructural aberrations and cytochrome c release:involvement of nitric oxide synthase and protein tyrosine nitration. Clin Sci (Lond) 2005;109:277-86.
19. Beard JL, Connor JR. Iron status and neural functioning. Annu Rev Nutr 2003;23:41-58.
20. Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 2007;85:778-87.
21. Davies KJ, Maguire JJ, Brooks GA, Dallman PR, Packer L. Musclemitochondrial bioenergetics, oxygen supply, and work capac-ity during dietary iron deficiency and repletion. Am J Physiol 1982;242:E418-27.
22. Falkingham M, Abdelhamid A, Curtis P, Fairweather-Tait S, Dye L, Hooper L. The effects of oral iron supplementation on cog-nition in older children and adults: a systematic review andmeta-analysis. Nutr J 2010;9:4.
23. Maeder MT, Khammy O, dos Remedios C, Kaye DM. Myocar-dial and systemic iron depletion in heart failure implicationsfor anemia accompanying heart failure. J Am Coll Cardiol 2011;58:474-80.
24. Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008;52:501-11.
25. de Silva R, Rigby AS, Witte KK, et al. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol 2006;98:391-8.
26. Kalra PR, Bolger AP, Francis DP, et al. Effect of anemia on exer-cise tolerance in chronic heart failure in men. Am J Cardiol 2003;91:888-91.
27. Nanas JN, Matsouka C, Karageorgopoulos D, et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Car-diol 2006;48:2485-9.
28. Opasich C, Cazzola M, Scelsi L, et al. Blunted erythropoi-etin production and defective iron supply for erythropoiesis asmajor causes of anaemia in patients with chronic heart failure. Eur Heart J 2005;26:2232-7.
29. Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL. Are hematinic deficiencies the cause of anemia inchronic heart failure? Am Heart J 2004;147:924-30.
30. Cohen-Solal A, Damy T, Hanon O, et al. High prevalence of iron deficiency in patients admitted for acute decompensatedheart failure: a French study (Cardiofer). J Am Coll Cardiol 2014;63:A779.
31. Assessing the iron status of populations: Report of a Joint World Health Organization/Centers for Disease Control and Prevention Technical Consultation on the Assessment of Iron Status atthe Population Level, Geneva, Switzerland, 6-8 April 2004. 2nd ed., including literature reviews. Available at: http://apps.who.int/iris/bitstream/10665/75368/1/9789241596107 eng.pdf?ua=1
32. WHO. Serum ferritin concentrations for the assessmentof iron status and iron deficiency in populations. Vita-min and Mineral Nutrition Information System. Geneva:World Health Organization; 2011 [WHO/NMH/NHD/MNM/11.2]http://www.who.int/vmnis/indicators/serum ferritin.pdf
33. Coenen JL, van Dieijen-Visser MP, van Pelt J, et al. Mea-surements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease. Clin Chem 1991;37:560-3.
34. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelinesfor the diagnosis and treatment of acute and chronic heartfailure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-69.
35. Haute Autorité de santé. http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-11/texte court bilanmartial carence 2011-11-09 17-22-2 135.pdf
36. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHAguideline for the management of heart failure: executivesummary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practiceguidelines. Circulation 2013;128:1810-52.
37. Anker SD, Colet JC, Filippatos G, et al. Rationale and design of Ferinject assessment in patients with iron defi-ciency and chronic heart failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementationin patients with and without anaemia. Eur J Heart Fail 2009;11:1084-91.
38. Beck-da-Silva L, Rohde LE, Pereira-Barretto AC, et al. Rationaleand design of the IRON-HF study: a randomized trial to assessthe effects of iron supplementation in heart failure patientswith anemia. J Card Fail 2007;13:14-7.
39. Sandek A, Bauditz J, Swidsinski A, et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007;50:1561-9.